![]() |
![]() |
![]() |
Ecstasy use leads to feelings of euphoria, confidence, anxiety and an increased awareness of the senses. It also causes an increase in heart rate, sickness, dilated pupils, a clenching of the jaw and difficulty walking straight.
The high resulting from one or two ecstasy tablets lasts for 3-5 hrs and the “hangover”, characterised by muscle aches, fatigue and a depressed feeling, can last for several days. Most people do not take ecstasy more than once a week as the effects become less ecstatic the more regularly it is taken.
The brain has a variety of messengers that its cells use to communicate
with each other. Ecstasy works primarily by interfering with a messenger
called 5-hydroxytryptamine which is abbreviated to 5-HT and is also known
as Serotonin. Scientists are still arguing about what sort of effects
ecstasy has on other messengers in the brain.
Back to chemical culture
Epidemiology
The UK, along with Ireland and the Netherlands, boasts one of the worlds
highest rates of ecstasy use, with more than a million people thought to
have tried it. Most of these people are 18-29 yrs of age.
It is very difficult to know exactly how many people have tried ecstasy
because of the fact that it is illegal.
Back to epidemiology
The 5-HT System
A series of enzymes make 5-HT from Tryptophan, which we eat in things
like cheese and chocolate. The slowest of these enzymes is called
Tryptophan hydroxylase. This enzyme is particularly important because
how fast we can make 5-HT depends on how fast our tryptophan hydroxylase
is working. Cells in the brain store most of the 5-HT they have made
in little bubbles, called vesicles, which they spit out when they want
to send a message to a neighbouring cell. The rest of the 5-HT gets
left in the cells internal fluid. After a cell has spat out
a few 5-HT vesicles, when it is sending a message, the 5-HT effectively
flicks a switch on the neighbouring cell which tells this cell that it
is receiving a message. The 5-HT is then pumped by its own special
pump back into the cell it came from, where it is either repackaged in
more vesicles or broken down to form a waste product called 5-hydroxyindolacetic
acid
which is abbreviated as 5-HIAA. Some people have measured 5-HIAA
levels to try and determine how much damage ecstasy does, as we will see
later.
Back to the 5-HT system
How MDMA Becomes Ecstasy
Ecstasy works by blocking the pump which pumps 5-HT back into the cell
it came from after it has been released to send a message. It also
causes a lot of the 5-HT which was not packaged into vesicles (see
above) to be forced out of the cell and into the gap between the cells.
This has the overall effect of leaving loads of 5-HT in the gap between
the cells instead of inside the first cell where it belongs.
To send a message normally the 5-HT just has to flick the switch on the
cell it is trying to communicate with once, when there is so much 5-HT
outside the cell however it continues flicking the switch which leaves
that cell rather confused. There are many different types of
switches, which can be on a cells surface and it is thought that as well
as the aforementioned actions, ecstasy interferes directly with some of
these switches. Scientists do not all agree about which switches
are affected by ecstasy and the situation is further complicated because,
although ecstasy works mostly on the 5-HT system it probably also affects
some of the switches which other messengers use and therefore also affects
there actions.
Back to how MDMA becomes ecstasy
Animal Studies
The levels of 5-HT in the brains of rats show the same pattern of changes
that peoples behaviour exhibits after taking ecstasy, supporting the idea
that it is the levels of 5-HT outside the cells which make ecstasy work.
A dose of ecstasy also slows down the tryptophan hydroxlase enzyme
in rats brains. You may remember we earlier mentioned that how much 5-HT
we can make depends on how fast our tryptophan hydoxylase is working.
It has been shown that ecstasy can kill off some of the nerve cells that
it affects, however it would appear that to do this requires either a large
dose or many smaller doses. This damage has been shown to last for
over a year in rats and over seven years in monkeys. The doses shown
to cause long term damage have been bigger than those normally taken by
people but, because we have bigger brains, we are more susceptible than
other animals to drugs which potentially damage the brain.
Back to animal studies
Clinical Assessment
It is very difficult to assess the damage ecstasy does to people as
it would not be allowed to do a controlled trial involving giving people
ecstasy and measuring the effects. Several studies have been done
comparing ecstasy users to people who have never used it. There is
a big problem though, in that most ecstasy users have used other sorts
of drugs as well so no one really knows which drug has done any damage
that is found. People have tried measuring levels of the waste product
5-HIAA (see above) and have shown that ecstasy users
have less of it than other people, which supports the idea that ecstasy
interferes with tryptophan hydroxlase (see above).
Other people have tried giving a legal drug called fenfluramine, which
is similar to ecstasy, to ecstasy users and non ecstasy users and measuring
the difference in responses. The Ecstasy users showed less of a response
and therefore can be considered to have developed some kind of tolerance
to this type of drug. This tolerance appears to be long lasting.
back to clincal assessment
Neuroimaging
Another approach to be tried is taking a variety of types of pictures
of the brains of both ecstasy users and non users. These have, in my opinion,
provided the best evidence so far that ecstasy damages the brain. They
have shown decreased activity of several types of pump involved with the
5-HT system and an increased number of the switches which 5-HT uses to
pass on messages, probably as a response to lower levels of 5-HT. Thy have
even shown an overall decrease in the volume of the brain.
back to neuroimaging
The Parkinson Paradox
It is thought that the action of ecstasy on the 5-HT system indirectly
interferes with another messenger called dopamine. A shortage of
dopamine in certain parts of the brain causes Parkinsons disease and therefore
ecstasy should make parkinsons symptoms worse. However the therapy
for parkinsons, L-Dopa, causes serious side effects in that it makes previously
underactive nerve cells activate themselves erratically causing jerky movements.
It has recently been reported that ecstasy when given with L-Dopa, relieves
these side effects, probably by stopping the excessive activation of the
nerves which control movement. Therefore a drug which should in theory
make parkinsons disease worse has the potential to form a useful part of
its therapy.
Back to the parkinson paradox
Still in two minds?
It has been suggested that it is not direct damage to nerves which
causes the long term effects sometimes reported to result from ecstasy
use but rather the bad memory of a bad trip – sound like a theory dreamed
up while on ecstasy? Perhaps, but then that’s the fun of science – if you
can justify it you can believe it!
Back to still in two minds
In conclusion
This section is not accounted as it contains little jargon and is written
in the best inglish wot I know guv!
Back to in conclusion